论文部分内容阅读
本文前瞻性评价了甲孕酮在中、重度子宫内膜异位症处理中的效果、临床反应,患者对这种治疗的耐受性、内分泌情况,以及子宫内膜和子宫内膜异位症移植片的组织学变化。本研究对象为经腹腔镜检查证实为子宫内膜异位症的21例患者。病灶范围按照美国生殖协会最初的分类法分期,根据同一分类体系确定每例患者病灶的总评分。治疗方案是:从月经周期的第三天开始口服甲孕酮50mg/日,共4个月,治疗前一周及此后每月询问患者有关出血和症状的情况以及治疗的副作用,并且每月随查盆腔情况。在治疗前月经
This prospective evaluation of medroxyprogesterone in the treatment of moderate and severe endometriosis, the clinical response, the patient’s tolerance to this treatment, endocrine conditions, and endometrial and endometriosis Histological changes in the graft. This study was performed on 21 patients with endometriosis confirmed by laparoscopy. The extent of the lesion was staged according to the initial classification of the American Reproductive Association and the total score of each patient’s lesion was determined according to the same classification system. The regimen was: oral administration of MPP 50 mg / day starting on the third day of the menstrual cycle for a total of 4 months, the patient being asked about bleeding and symptoms and the side effects of the treatment one month prior to treatment and thereafter thereafter, Pelvic situation. Menstruation before treatment